-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Fulcrum Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2018 to 2024.
- Fulcrum Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$25.3M, a 4.84% decline year-over-year.
- Fulcrum Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$2.22M, a 97.6% increase from 2023.
- Fulcrum Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$91M, a 6.27% increase from 2022.
- Fulcrum Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$97.1M, a 23.7% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)